Vaxil Bio VXLLF Stock
Vaxil Bio Price Chart
Vaxil Bio VXLLF Financial and Trading Overview
| Vaxil Bio stock price | 0.02 USD |
| Previous Close | 0.02 USD |
| Open | 0.16 USD |
| Bid | 0.03 USD x 4000000 |
| Ask | 0.69 USD x 200000 |
| Day's Range | 0.16 - 0.16 USD |
| 52 Week Range | 0.0021 - 0.5 USD |
| Volume | 500 USD |
| Avg. Volume | 1.5K USD |
| Market Cap | 88.05K USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 0.17 |
| EPS (TTM) | 0.13 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VXLLF Valuation Measures
| Enterprise Value | -1123953 USD |
| Trailing P/E | 0.17 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.12645684 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Vaxil Bio Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -85.72% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.5 USD |
| 52 Week Low | 0.0021 USD |
| 50-Day Moving Average | 0.07 USD |
| 200-Day Moving Average | 0.08 USD |
VXLLF Share Statistics
| Avg. Volume (3 month) | 1.5K USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 3.98M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 5.61% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:50 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -13.52% |
| Return on Equity (ttm) | 50.89% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | 484K USD |
| Diluted EPS (ttm) | 0.13 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.21M USD |
| Total Cash Per Share (mrq) | 0.3 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 35.944 |
| Book Value Per Share (mrq) | 0.17476317 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -267000 USD |
| Levered Free Cash Flow (ttm) | 61.25K USD |
Profile of Vaxil Bio
| Country | United States |
| State | ON |
| City | Toronto |
| Address | 559 Briar Hill Avenue |
| ZIP | M5N 1N1 |
| Phone | N/A |
| Website | N/A |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Vaxil Bio Ltd., a biotechnology company, focuses on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. Its lead product candidate is ImMucin, a MUC1 SP-based vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. The company is headquartered in Toronto, Canada.
Q&A For Vaxil Bio Stock
What is a current VXLLF stock price?
Vaxil Bio VXLLF stock price today per share is 0.02 USD.
How to purchase Vaxil Bio stock?
You can buy VXLLF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vaxil Bio?
The stock symbol or ticker of Vaxil Bio is VXLLF.
Which industry does the Vaxil Bio company belong to?
The Vaxil Bio industry is Biotechnology.
How many shares does Vaxil Bio have in circulation?
The max supply of Vaxil Bio shares is 3.98M.
What is Vaxil Bio Price to Earnings Ratio (PE Ratio)?
Vaxil Bio PE Ratio is 0.17000000 now.
What was Vaxil Bio earnings per share over the trailing 12 months (TTM)?
Vaxil Bio EPS is 0.13 USD over the trailing 12 months.
Which sector does the Vaxil Bio company belong to?
The Vaxil Bio sector is Healthcare.